Anthracene-9, 10-dione derivatives induced apoptosis in human cervical cancer cell line (CaSki) by interfering with HPV E6 expression

European Journal of Medicinal Chemistry

Volumn 77, Issue , 2014, Pages 334-342

  Sangthong, Supranee ^a   Sangphech, Naunpun ^a   Palaga, Tanapat ^a   Ngamrojanavanich, Nattaya ^a   Puthong, Songchan ^a   Vilaivan, Tirayut ^a   Muangsin, Nongnuj ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

10 Dione; Anthracene 9; Apoptosis; Cell cycle; Cervical cancer; HPV E6; p53

Indexed keywords

4 (BENZYLAMINO) 9,10 DIOXO 4A,9,9A,10 TETRAHYDROANTHRACEN 1 YL 4 METHYLBENZENESUL; 4 (DIETHYLAMINO) 9,10 DIOXO 4A,9,9A,10 TETRAHYDROANTHRACEN 1 YL 4 METHYLBENZENESULFONATE; 9,10 DIOXO 4 (PHENETHYLAMINO) 4A,9,9A,10 TETRAHYDROANTHRACEN 1 YL 4 METHYLBENZENESULFONATE; ANTHRACENE 9,10 DIONE DERIVATIVE; ANTHRACENE DERIVATIVE; CISPLATIN; CYTOTOXIC AGENT; DAUNORUBICIN; PROTEIN BCL 2; PROTEIN E6; PROTEIN P53; UNCLASSIFIED DRUG; 9,10-ANTHRAQUINONE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME CONDENSATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; FLUORESCENCE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IC 50; IN VITRO STUDY; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; WART VIRUS; BIOSYNTHESIS; CELL CYCLE; CHEMICAL STRUCTURE; CHEMISTRY; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; GENETICS; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84896467025     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.02.006     Document Type: Article

References (24)

1. J.A. DiPaolo, and L.M. Alvarez-Salas Advances in the development of therapeutic nucleic acids against cervical cancer Expert Opinion on Biological Therapy 4 8 2004 1251 1264 (Pubitemid 39005732)
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA: a Cancer Journal for Clinicians 55 2 2005 74 108 (Pubitemid 40372904)
3. P. Kaur, J.K. McDougall, and R. Cone Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames The Journal of General Virology 70 Pt 5 1989 1261 1266 (Pubitemid 19131634)
4. M. Scheffner Ubiquitin, E6-AP, and their role in p53 inactivation Pharmacology & Therapeutics 78 3 1998 129 139 (Pubitemid 28255145)
5. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nature Reviews Cancer 2 8 2002 594 604 (Pubitemid 37328926)
6. H. Cui, A. Schroering, and H.F. Ding p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells Molecular Cancer Therapeutics 1 9 2002 679 686
7. E.S. Alnemri, T.F. Fernandes, S. Haldar, C.M. Croce, and G. Litwack Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias Cancer Research 52 2 1992 491 495
8. T.C. Fisher et al. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways Cancer Research 53 14 1993 3321 3326 (Pubitemid 23223304)
9. G. Bossi, and A. Sacchi Restoration of wild-type p53 function in human cancer: relevance for tumor therapy Head & Neck 29 3 2007 272 284 (Pubitemid 46339325)
10. R.C. Jordan, G.C. Catzavelos, A.W. Barrett, and P.M. Speight Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity European Journal of Cancer. Part B, Oral Oncology 32B 6 1996 394 400
11. S. Atula, K. Kurvinen, R. Grenman, and S. Syrjanen SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer European Journal of Cancer. Part B, Oral Oncology 32B 4 1996 222 229
12. Q.L. Lu, G. Elia, S. Lucas, and J.A. Thomas Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma International Journal of Cancer. Journal International du Cancer 53 1 1993 29 35 (Pubitemid 23018418)
13. S.G. Lutzker, and A.J. Levine A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation Nature Medicine 2 7 1996 804 810 (Pubitemid 26225098)
14. P.J. Loehrer, and L.H. Einhorn Drugs five years later Cisplatin. Annals of Internal Medicine 100 5 1984 704 713
15. J.D. McEvoy, S.R. Crooks, C.T. Elliott, W.J. McCaughey, and D.G. Kennedy Origin of chlortetracycline in pig tissue The Analyst 119 12 1994 2603 2606
16. M.T. Kuo Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities Antioxidants & Redox Signaling 11 1 2009 99 133
17. Z.H. Siddik Cisplatin: mode of cytotoxic action and molecular basis of resistance Oncogene 22 47 2003 7265 7279 (Pubitemid 37487159)
18. B. Mannervik, and U.H. Danielson Glutathione transferases - structure and catalytic activity CRC Critical Reviews in Biochemistry 23 3 1988 283 337
19. S. Sangthong et al. Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives Bioorganic & Medicinal Chemistry Letters 23 22 2013 6156 6160
20. K. Kawano et al. Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or death Cancer Research 65 7 2005 2930 2937 (Pubitemid 40490098)
21. S. Sangthong et al. Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities Bioorganic & Medicinal Chemistry Letters 21 16 2011 4813 4818
22. J. Cai et al. Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis Neoplasia 10 1 2008 41 51 (Pubitemid 351170711)
23. V. Bilim, T. Kawasaki, K. Takahashi, and Y. Tomita Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes Journal of Experimental & Clinical Cancer Research: CR 19 4 2000 483 488 (Pubitemid 32209848)
24. G.M. Sheldrick A short history of SHELX Acta Crystallographica. Section A, Foundations of Crystallography 64 Pt 1 2008 112 122